nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—membranous glomerulonephritis	0.713	1	CbGaD
Gefitinib—STK10—renal vein—membranous glomerulonephritis	0.0978	0.538	CbGeAlD
Gefitinib—ERBB3—nephron tubule—membranous glomerulonephritis	0.00642	0.0353	CbGeAlD
Gefitinib—ERBB3—epithelium—membranous glomerulonephritis	0.00629	0.0346	CbGeAlD
Gefitinib—MKNK2—nephron tubule—membranous glomerulonephritis	0.0061	0.0336	CbGeAlD
Gefitinib—IRAK1—nephron tubule—membranous glomerulonephritis	0.0061	0.0336	CbGeAlD
Gefitinib—MKNK2—epithelium—membranous glomerulonephritis	0.00598	0.0329	CbGeAlD
Gefitinib—CSNK1E—cortex of kidney—membranous glomerulonephritis	0.00569	0.0313	CbGeAlD
Gefitinib—ERBB3—kidney—membranous glomerulonephritis	0.00564	0.031	CbGeAlD
Gefitinib—MKNK2—cortex of kidney—membranous glomerulonephritis	0.00522	0.0287	CbGeAlD
Gefitinib—IRAK1—cortex of kidney—membranous glomerulonephritis	0.00522	0.0287	CbGeAlD
Gefitinib—MKNK1—cortex of kidney—membranous glomerulonephritis	0.00516	0.0284	CbGeAlD
Gefitinib—STK10—kidney—membranous glomerulonephritis	0.00436	0.024	CbGeAlD
Gefitinib—MAP2K5—cortex of kidney—membranous glomerulonephritis	0.00379	0.0209	CbGeAlD
Gefitinib—ABCG2—nephron tubule—membranous glomerulonephritis	0.00216	0.0119	CbGeAlD
Gefitinib—CYP1A1—epithelium—membranous glomerulonephritis	0.00201	0.011	CbGeAlD
Gefitinib—CYP3A5—nephron tubule—membranous glomerulonephritis	0.002	0.011	CbGeAlD
Gefitinib—CYP1A1—kidney—membranous glomerulonephritis	0.0018	0.00989	CbGeAlD
Gefitinib—CYP3A5—kidney—membranous glomerulonephritis	0.00176	0.00967	CbGeAlD
Gefitinib—CYP3A5—cortex of kidney—membranous glomerulonephritis	0.00171	0.00942	CbGeAlD
Gefitinib—CYP3A4—kidney—membranous glomerulonephritis	0.00132	0.00726	CbGeAlD
Gefitinib—CYP2D6—kidney—membranous glomerulonephritis	0.0013	0.00714	CbGeAlD
Gefitinib—Erlotinib—ALB—membranous glomerulonephritis	0.00121	0.603	CrCbGaD
Gefitinib—ABCB1—nephron tubule—membranous glomerulonephritis	0.00106	0.00585	CbGeAlD
Gefitinib—ABCB1—epithelium—membranous glomerulonephritis	0.00104	0.00573	CbGeAlD
Gefitinib—ABCB1—kidney—membranous glomerulonephritis	0.000934	0.00514	CbGeAlD
Gefitinib—ABCB1—cortex of kidney—membranous glomerulonephritis	0.00091	0.00501	CbGeAlD
Gefitinib—Vandetanib—ALB—membranous glomerulonephritis	0.000795	0.397	CrCbGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—IL1B—membranous glomerulonephritis	0.000219	0.00212	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by Wnt—RHOA—membranous glomerulonephritis	0.000212	0.00205	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CFH—membranous glomerulonephritis	0.000209	0.00202	CbGpPWpGaD
Gefitinib—ALB—Platelet degranulation—APOA1—membranous glomerulonephritis	0.000203	0.00197	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD40—membranous glomerulonephritis	0.000201	0.00194	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—RHOA—membranous glomerulonephritis	0.000198	0.00192	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000198	0.00191	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—MMP9—membranous glomerulonephritis	0.000196	0.00189	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—C3—membranous glomerulonephritis	0.000196	0.00189	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—membranous glomerulonephritis	0.000194	0.00187	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HLA-DRB1—membranous glomerulonephritis	0.000192	0.00185	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD79A—membranous glomerulonephritis	0.000189	0.00183	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000188	0.00182	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—IL1B—membranous glomerulonephritis	0.000188	0.00182	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—IL1B—membranous glomerulonephritis	0.000188	0.00182	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000184	0.00178	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CFH—membranous glomerulonephritis	0.000182	0.00176	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—RHOA—membranous glomerulonephritis	0.000182	0.00176	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—membranous glomerulonephritis	0.000179	0.00173	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.000178	0.00172	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—C3—membranous glomerulonephritis	0.000178	0.00172	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—RHOA—membranous glomerulonephritis	0.000176	0.0017	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—RHOA—membranous glomerulonephritis	0.000175	0.00169	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	0.000174	0.00169	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—APOA1—membranous glomerulonephritis	0.000173	0.00167	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—SPARC—membranous glomerulonephritis	0.00017	0.00165	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—membranous glomerulonephritis	0.000169	0.00164	CbGpPWpGaD
Gefitinib—ERBB3—Disease—LRP2—membranous glomerulonephritis	0.000167	0.00162	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.000167	0.00161	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—RHOA—membranous glomerulonephritis	0.000164	0.00159	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000159	0.00154	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.000157	0.00152	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD40LG—membranous glomerulonephritis	0.000154	0.00149	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000154	0.00149	CbGpPWpGaD
Gefitinib—EGFR—Immune System—C7—membranous glomerulonephritis	0.000154	0.00149	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD40—membranous glomerulonephritis	0.000153	0.00148	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—IL1B—membranous glomerulonephritis	0.000153	0.00148	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—RHOA—membranous glomerulonephritis	0.000146	0.00141	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD79A—membranous glomerulonephritis	0.000144	0.00139	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—C3—membranous glomerulonephritis	0.000142	0.00137	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—MMP9—membranous glomerulonephritis	0.00014	0.00135	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—MMP9—membranous glomerulonephritis	0.000136	0.00132	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—C3—membranous glomerulonephritis	0.000136	0.00132	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—RHOA—membranous glomerulonephritis	0.000135	0.00131	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000133	0.00128	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—PLG—membranous glomerulonephritis	0.000129	0.00125	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—RHOA—membranous glomerulonephritis	0.000127	0.00123	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—IL1B—membranous glomerulonephritis	0.000126	0.00122	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—IL1B—membranous glomerulonephritis	0.000125	0.00121	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000124	0.0012	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	0.000124	0.0012	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD40—membranous glomerulonephritis	0.000122	0.00118	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CFH—membranous glomerulonephritis	0.000122	0.00118	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000122	0.00118	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000121	0.00117	CbGpPWpGaD
Gefitinib—MKNK1—Disease—APOE—membranous glomerulonephritis	0.00012	0.00116	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—PLG—membranous glomerulonephritis	0.000119	0.00115	CbGpPWpGaD
Gefitinib—MKNK1—Disease—APOA1—membranous glomerulonephritis	0.000118	0.00115	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—C3—membranous glomerulonephritis	0.000118	0.00114	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000117	0.00113	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD40LG—membranous glomerulonephritis	0.000117	0.00113	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—membranous glomerulonephritis	0.000117	0.00113	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.000116	0.00112	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD79A—membranous glomerulonephritis	0.000115	0.00111	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000113	0.0011	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD40—membranous glomerulonephritis	0.000112	0.00108	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000111	0.00107	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000107	0.00103	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000106	0.00102	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD79A—membranous glomerulonephritis	0.000105	0.00102	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—C3—membranous glomerulonephritis	0.000104	0.001	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000102	0.000984	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD40—membranous glomerulonephritis	0.000102	0.000982	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000101	0.000977	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LRP2—membranous glomerulonephritis	9.76e-05	0.000944	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—RHOA—membranous glomerulonephritis	9.75e-05	0.000943	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	9.72e-05	0.00094	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	9.71e-05	0.000939	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD79A—membranous glomerulonephritis	9.54e-05	0.000923	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HLA-DRB1—membranous glomerulonephritis	9.44e-05	0.000913	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD40LG—membranous glomerulonephritis	9.34e-05	0.000904	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	9.32e-05	0.000902	CbGpPWpGaD
Gefitinib—EGFR—Disease—LRP2—membranous glomerulonephritis	9.32e-05	0.000902	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—APOE—membranous glomerulonephritis	9.32e-05	0.000901	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	9.28e-05	0.000897	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PLG—membranous glomerulonephritis	9.22e-05	0.000892	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—APOA1—membranous glomerulonephritis	9.21e-05	0.000891	CbGpPWpGaD
Gefitinib—MKNK1—Disease—RHOA—membranous glomerulonephritis	9.07e-05	0.000877	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	9.07e-05	0.000877	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—APOA1—membranous glomerulonephritis	9.02e-05	0.000872	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—C3—membranous glomerulonephritis	9.01e-05	0.000872	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—RHOA—membranous glomerulonephritis	8.83e-05	0.000854	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-DQA1—membranous glomerulonephritis	8.81e-05	0.000852	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SPARC—membranous glomerulonephritis	8.77e-05	0.000848	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	8.73e-05	0.000844	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD40LG—membranous glomerulonephritis	8.58e-05	0.00083	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—APOE—membranous glomerulonephritis	8.39e-05	0.000811	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—APOA1—membranous glomerulonephritis	8.29e-05	0.000802	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	8.27e-05	0.0008	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—C3—membranous glomerulonephritis	8.26e-05	0.000799	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TBXAS1—membranous glomerulonephritis	8.18e-05	0.000791	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	7.96e-05	0.00077	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—C3—membranous glomerulonephritis	7.89e-05	0.000763	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD40LG—membranous glomerulonephritis	7.78e-05	0.000752	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—C3—membranous glomerulonephritis	7.58e-05	0.000733	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HLA-DRB1—membranous glomerulonephritis	7.52e-05	0.000728	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—LRP2—membranous glomerulonephritis	7.29e-05	0.000705	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PLG—membranous glomerulonephritis	7.29e-05	0.000705	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	7.14e-05	0.000691	CbGpPWpGaD
Gefitinib—ERBB3—Disease—APOE—membranous glomerulonephritis	7.1e-05	0.000687	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—RHOA—membranous glomerulonephritis	7.05e-05	0.000682	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PLG—membranous glomerulonephritis	7.03e-05	0.00068	CbGpPWpGaD
Gefitinib—ERBB3—Disease—APOA1—membranous glomerulonephritis	7.02e-05	0.000679	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PLA2G1B—membranous glomerulonephritis	7.02e-05	0.000679	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—MMP9—membranous glomerulonephritis	7.01e-05	0.000678	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—C3—membranous glomerulonephritis	7.01e-05	0.000678	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	6.91e-05	0.000668	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	6.91e-05	0.000668	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—C3—membranous glomerulonephritis	6.88e-05	0.000665	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD40—membranous glomerulonephritis	6.79e-05	0.000656	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—PLG—membranous glomerulonephritis	6.65e-05	0.000643	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LRP2—membranous glomerulonephritis	6.53e-05	0.000631	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—APOE—membranous glomerulonephritis	6.52e-05	0.000631	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	6.52e-05	0.000631	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	6.51e-05	0.000629	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—APOA1—membranous glomerulonephritis	6.45e-05	0.000624	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD79A—membranous glomerulonephritis	6.38e-05	0.000617	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—RHOA—membranous glomerulonephritis	6.35e-05	0.000614	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—RHOA—membranous glomerulonephritis	6.3e-05	0.000609	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-DRB1—membranous glomerulonephritis	6.26e-05	0.000606	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL1B—membranous glomerulonephritis	6.15e-05	0.000595	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DQA1—membranous glomerulonephritis	5.89e-05	0.00057	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TBXAS1—membranous glomerulonephritis	5.86e-05	0.000567	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PLG—membranous glomerulonephritis	5.85e-05	0.000566	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	5.84e-05	0.000565	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	5.75e-05	0.000556	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—C3—membranous glomerulonephritis	5.54e-05	0.000536	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TBXAS1—membranous glomerulonephritis	5.54e-05	0.000535	CbGpPWpGaD
Gefitinib—ERBB3—Disease—RHOA—membranous glomerulonephritis	5.37e-05	0.00052	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—C3—membranous glomerulonephritis	5.34e-05	0.000516	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	5.33e-05	0.000515	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—LRP2—membranous glomerulonephritis	5.22e-05	0.000505	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD40LG—membranous glomerulonephritis	5.2e-05	0.000503	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	5.17e-05	0.0005	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—APOE—membranous glomerulonephritis	5.16e-05	0.000499	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—APOA1—membranous glomerulonephritis	5.1e-05	0.000493	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TBXAS1—membranous glomerulonephritis	5.05e-05	0.000488	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP9—membranous glomerulonephritis	5.04e-05	0.000488	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	5.04e-05	0.000488	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—C3—membranous glomerulonephritis	5.03e-05	0.000487	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PLA2G1B—membranous glomerulonephritis	5.03e-05	0.000486	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP9—membranous glomerulonephritis	5e-05	0.000484	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—APOE—membranous glomerulonephritis	4.97e-05	0.000481	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RHOA—membranous glomerulonephritis	4.94e-05	0.000478	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—LRP2—membranous glomerulonephritis	4.93e-05	0.000477	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—APOA1—membranous glomerulonephritis	4.91e-05	0.000475	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—membranous glomerulonephritis	4.9e-05	0.000474	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PLA2G1B—membranous glomerulonephritis	4.75e-05	0.000459	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ABCA1—membranous glomerulonephritis	4.7e-05	0.000454	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	4.7e-05	0.000454	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—APOA1—membranous glomerulonephritis	4.65e-05	0.00045	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	4.64e-05	0.000449	CbGpPWpGaD
Gefitinib—EGFR—Immune System—C3—membranous glomerulonephritis	4.6e-05	0.000445	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TBXAS1—membranous glomerulonephritis	4.53e-05	0.000438	CbGpPWpGaD
Gefitinib—ALB—Metabolism—LRP2—membranous glomerulonephritis	4.5e-05	0.000435	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—C3—membranous glomerulonephritis	4.45e-05	0.00043	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	4.42e-05	0.000428	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PLA2G1B—membranous glomerulonephritis	4.33e-05	0.000419	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	4.28e-05	0.000414	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	4.23e-05	0.000409	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—membranous glomerulonephritis	4.19e-05	0.000405	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TBXAS1—membranous glomerulonephritis	4.17e-05	0.000403	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—APOE—membranous glomerulonephritis	4.14e-05	0.0004	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TBXAS1—membranous glomerulonephritis	4.13e-05	0.0004	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—APOA1—membranous glomerulonephritis	4.09e-05	0.000396	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—membranous glomerulonephritis	4.08e-05	0.000395	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LRP2—membranous glomerulonephritis	4.04e-05	0.000391	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	4.02e-05	0.000389	CbGpPWpGaD
Gefitinib—EGFR—Disease—APOE—membranous glomerulonephritis	3.95e-05	0.000382	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	3.94e-05	0.000381	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—membranous glomerulonephritis	3.92e-05	0.000379	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PLG—membranous glomerulonephritis	3.91e-05	0.000378	CbGpPWpGaD
Gefitinib—EGFR—Disease—APOA1—membranous glomerulonephritis	3.91e-05	0.000378	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RHOA—membranous glomerulonephritis	3.9e-05	0.000378	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PLA2G1B—membranous glomerulonephritis	3.89e-05	0.000376	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	3.84e-05	0.000372	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	3.8e-05	0.000367	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	3.79e-05	0.000367	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RHOA—membranous glomerulonephritis	3.76e-05	0.000364	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LRP2—membranous glomerulonephritis	3.71e-05	0.000359	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LRP2—membranous glomerulonephritis	3.68e-05	0.000356	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	3.68e-05	0.000356	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PLA2G1B—membranous glomerulonephritis	3.57e-05	0.000346	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—RHOA—membranous glomerulonephritis	3.56e-05	0.000344	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—RHOA—membranous glomerulonephritis	3.55e-05	0.000343	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PLA2G1B—membranous glomerulonephritis	3.54e-05	0.000343	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	3.53e-05	0.000341	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	3.5e-05	0.000339	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	3.46e-05	0.000335	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCA1—membranous glomerulonephritis	3.37e-05	0.000326	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCA1—membranous glomerulonephritis	3.18e-05	0.000308	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.13e-05	0.000303	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—membranous glomerulonephritis	3.1e-05	0.0003	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOE—membranous glomerulonephritis	3.09e-05	0.000299	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOA1—membranous glomerulonephritis	3.05e-05	0.000295	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	3.01e-05	0.000291	CbGpPWpGaD
Gefitinib—EGFR—Disease—RHOA—membranous glomerulonephritis	2.99e-05	0.000289	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—membranous glomerulonephritis	2.99e-05	0.000289	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—C3—membranous glomerulonephritis	2.97e-05	0.000287	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCA1—membranous glomerulonephritis	2.9e-05	0.00028	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	2.79e-05	0.00027	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOE—membranous glomerulonephritis	2.77e-05	0.000268	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	2.74e-05	0.000265	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOA1—membranous glomerulonephritis	2.74e-05	0.000265	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—membranous glomerulonephritis	2.73e-05	0.000264	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	2.72e-05	0.000263	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCA1—membranous glomerulonephritis	2.6e-05	0.000252	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	2.54e-05	0.000246	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.49e-05	0.000241	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	2.43e-05	0.000235	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—membranous glomerulonephritis	2.42e-05	0.000234	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCA1—membranous glomerulonephritis	2.39e-05	0.000231	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCA1—membranous glomerulonephritis	2.37e-05	0.000229	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	2.34e-05	0.000226	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOE—membranous glomerulonephritis	2.21e-05	0.000214	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOA1—membranous glomerulonephritis	2.19e-05	0.000212	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RHOA—membranous glomerulonephritis	2.09e-05	0.000203	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—membranous glomerulonephritis	2.09e-05	0.000202	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOA1—membranous glomerulonephritis	2.07e-05	0.0002	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—membranous glomerulonephritis	1.91e-05	0.000184	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOA1—membranous glomerulonephritis	1.88e-05	0.000182	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—membranous glomerulonephritis	1.73e-05	0.000168	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—membranous glomerulonephritis	1.71e-05	0.000166	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOA1—membranous glomerulonephritis	1.69e-05	0.000164	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—membranous glomerulonephritis	1.67e-05	0.000162	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—membranous glomerulonephritis	1.66e-05	0.000161	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	1.65e-05	0.00016	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—membranous glomerulonephritis	1.64e-05	0.000158	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—membranous glomerulonephritis	1.57e-05	0.000152	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	1.56e-05	0.000151	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—membranous glomerulonephritis	1.56e-05	0.000151	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOA1—membranous glomerulonephritis	1.56e-05	0.00015	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOA1—membranous glomerulonephritis	1.54e-05	0.000149	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—membranous glomerulonephritis	1.34e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—membranous glomerulonephritis	1.31e-05	0.000127	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—membranous glomerulonephritis	1.23e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—membranous glomerulonephritis	1.22e-05	0.000118	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	1.03e-05	9.95e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	1.02e-05	9.84e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	8.06e-06	7.8e-05	CbGpPWpGaD
